Project: Prognostic miRNA-based test for left ventricular remodelling after acute myocardial infarction.
The consortium will develop an innovative diagnostic test to assess the risk of post-acute myocardial infarction (AMI) patients to develop life threatening heart failure (HF). A recently discovered prognostic set of 4 miRNAs will be validated and strengthened for use in a clinical test. Together with clinical information from the patient, the miRNA test will be developed into a new prognostic model for the identification of patients at risk to allow early treatment an monitor treatment response.
| Acronym | MIPROG (Reference Number: 9686) |
| Duration | 01/11/2015 - 01/11/2018 |
| Project Topic | Biological Sciences / Technologies |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 3 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 21319 | Firalis SAS | Coordinator | France |
| 21320 | Lifesequencing S.L. | Partner | Spain |
| 21321 | Luxembourg Institute of Health (LIH) | Partner | Luxembourg |
| 21322 | Medizinische Hochschule Hannover (MHH) | Partner | Germany |